ABDALLAH ALABADLA REMEMBERS THE NIGHT HE thought he was going to die. The college student had fled his home in Gaza City for Khan Younis, a place he thought would be safer. But soon after arriving, he found the city emptied of critical medical supplies.
"I went to every pharmacy in the area where I was staying, desperately looking for insulin," he said in a phone interview from Cairo, where he evacuated in March. "I thought I was going to die because I didn't find it. I don't know how to describe it. It was a horrible moment."
Alabadla, 23, was in his final semester at Al-Aqsa University, where he studied English literature before the October 7 attacks on Israel by Hamas and subsequent Israeli invasion of Gaza. He also has Type 1 diabetes and relies on taking insulin daily to stay alive.
Before the launch of Israel's offensive seeking to release the Israeli hostages and destroy Hamas, United Nations bodies estimated that up to 71,000 Palestinians in Gaza were living with diabetes as of November 2023. It is not known now how many of them have since fled or been killed.
Insulin is one of the medicines in "acute shortage" in Gaza, according to the World Health Organization, recalling a time before the advent of insulin therapy, when having diabetes-today considered a treatable condition-almost always meant a death sentence within a matter of days or weeks.
Alabadla and others say they have gone to extreme measures to survive the shortage. They now frequently switch between multiple types of insulin based on availability rather than what is recommended for their unique needs, use expired insulin or resort to insulin rationing-a potentially fatal practice.
Dr. Waseem Alzaanin is a physician in Deir al-Balah, in central Gaza. Like Alabadla, he has Type 1 diabetes.
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Ray Romano
THE MAJOR THING ABOUT NETFLIX'S NO GOOD DEED THAT APPEALED TO Ray Romano was that it was unlike anything he'd done before.
Has J.K. Rowling Won the Culture War?
After years of backlash over trans issues, the Harry Potter author has received major business backing
'This Murder Is a Symbol of the Times'
Conservatives and liberals agree on the state of the health care industry following the killing of Brian Thompson
The Defense Industry's Fight With ESG
EUROPEAN DEFENSE COMPANIES, ESPECIALLY smaller businesses, are being blocked from investment they sorely need by sustainability rules, a senior NATO official and several industry figures have said.
Nothin' Lasts Forever
Taylor Swift's Eras Tour' ends its record-breaking run..
SPY IN THE SKY
CHINA FACES ACCUSATIONS of ESPIONAGE and WEAPONIZING OUTER SPACE as it BUILDS a NEW OBSERVATORY in CHILE critics say WILL BE USED for MILITARY PURPOSES
Margo Martindale
\"WHO KNEW THAT A BARREL OF MAPLE SYRUP IS WORTH MORE THAN A barrel of oil?\"
Malala Yousafzai
\"AFGHANISTAN IS THE ONLY COUNTRY IN THE world where girls are banned from access to education and women are limited from work.\"
In the Eyes of the Law
Jude Law is unrecognizable as an FBI agent on the trail of aneo-Naziterrorist group in real-crime drama The Order
AMERICA'S Most Responsible Companies 2025
IN THE FACE OF ISSUES LIKE CLIMATE CHANGE and wage inequality, consumers care about the impact of the businesses they interact with and companies are responding.
